RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2018

Feb 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2018-02-14

Reporting Person: Van der Ploeg Leonardus H.T. (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-14	Employee Stock Option (Right to Buy)	$25.79	A	55000	Acquired	2028-02-13	Common Stock (55000)	Direct

Footnotes

F1: This option was granted on February 14, 2018 and the shares underlying this option vest in sixteen equal quarterly installments.